Literature DB >> 19387730

Retroperitoneal extraskeletal osteosarcoma: imaging findings and transarterial chemoembolization.

Huo-Jun Zhang1, Ji-Jin Yang, Jian-Ping Lu, Jin Sheng, Min Yuan, Xu Jiang, Yu-Xiao Li, Sanjay Gupta.   

Abstract

Extraskeletal osteosarcoma (EOS) is an uncommon and usually highly aggressive mesenchymal tumor. Retroperitoneal extraskeletal osteosarma (REOS) is exceedingly rare. Due to the rare nature of the disease, both the diagnosis and the management of REOS can be challenging. We present the clinical history, CT findings, angiographic manifestations, and use of transarterial chemoembolization for treatment in a case of REOS. To our knowledge, the angiographic features of and attempt at transarterial treatment of REOS have not been reported in the literature.

Entities:  

Mesh:

Year:  2009        PMID: 19387730     DOI: 10.1007/s00270-009-9575-x

Source DB:  PubMed          Journal:  Cardiovasc Intervent Radiol        ISSN: 0174-1551            Impact factor:   2.740


  4 in total

1.  Extra-skeletal osteosarcoma presenting as a peri-ampullary mass.

Authors:  Alexander Khalaf; Matthew T Heller
Journal:  J Gastrointest Cancer       Date:  2014-03

Review 2.  Primary extraskeletal osteosarcoma of the seminal vesicle: a case report and literature review.

Authors:  Jae Duck Choi; Yoon La Choi; Hong Seok Kim; Seong Il Seo; Seong Soo Jeon; Hyun Moo Lee; Byong Chang Jeong
Journal:  Ann R Coll Surg Engl       Date:  2011-05       Impact factor: 1.891

3.  Gastric wall implantation metastasis of retroperitoneal extraskeletal osteosarcoma: A case report and review of the literature.

Authors:  Yan Liu; Bin Hu; Jing-Xia Li; Lu-Qi Xing; Bao-Ping Liu
Journal:  Oncol Lett       Date:  2014-10-10       Impact factor: 2.967

Review 4.  Ossifying metaplasia of urothelial metastases: original case with review of the literature.

Authors:  Sana Boudabbous; Daniel Arditi; Emilie Paulin; Thibaud Koessler; Anne Laure Rougemont; Xavier Montet
Journal:  BMC Med Imaging       Date:  2015-08-12       Impact factor: 1.930

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.